EA200970663A1 - Лечение инфекционных болезней - Google Patents

Лечение инфекционных болезней

Info

Publication number
EA200970663A1
EA200970663A1 EA200970663A EA200970663A EA200970663A1 EA 200970663 A1 EA200970663 A1 EA 200970663A1 EA 200970663 A EA200970663 A EA 200970663A EA 200970663 A EA200970663 A EA 200970663A EA 200970663 A1 EA200970663 A1 EA 200970663A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
infectious diseases
infective agents
compositions
directed
Prior art date
Application number
EA200970663A
Other languages
English (en)
Other versions
EA016886B1 (ru
Inventor
Биргит Келгор Гиверкман
Original Assignee
Бкг Фарма Апс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бкг Фарма Апс filed Critical Бкг Фарма Апс
Publication of EA200970663A1 publication Critical patent/EA200970663A1/ru
Publication of EA016886B1 publication Critical patent/EA016886B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dairy Products (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

Данное изобретение направлено на определенные тиоксантеновые производные и фенотиазиновые производные, приемлемые для применения в качестве противоинфекционных средств, в частности, для лечения инфекционных болезней. Кроме того, данное изобретение касается композиций, включающих указанные противоинфекционные средства.
EA200970663A 2007-01-05 2008-01-07 Лечение инфекционных болезней EA016886B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/DK2007/000006 WO2008080398A1 (en) 2007-01-05 2007-01-05 Anti - infective agents such as phenothiazine and thioxanthene derivates to treat infectious diseases
PCT/DK2008/000005 WO2008080408A1 (en) 2007-01-05 2008-01-07 Thioxanthene derivates usefulto treat infectious diseases

Publications (2)

Publication Number Publication Date
EA200970663A1 true EA200970663A1 (ru) 2009-12-30
EA016886B1 EA016886B1 (ru) 2012-08-30

Family

ID=37914358

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200970663A EA016886B1 (ru) 2007-01-05 2008-01-07 Лечение инфекционных болезней

Country Status (18)

Country Link
US (1) US20100113430A1 (ru)
EP (2) EP2114406B1 (ru)
JP (2) JP5399921B2 (ru)
CN (1) CN101594869B (ru)
AT (1) ATE510540T1 (ru)
AU (1) AU2008203743B2 (ru)
CA (1) CA2673809C (ru)
CY (1) CY1111778T1 (ru)
DK (1) DK2114406T3 (ru)
EA (1) EA016886B1 (ru)
ES (1) ES2367151T3 (ru)
HK (1) HK1139309A1 (ru)
HR (1) HRP20110607T1 (ru)
MX (1) MX2009007235A (ru)
NZ (1) NZ577821A (ru)
PL (1) PL2114406T3 (ru)
PT (1) PT2114406E (ru)
WO (2) WO2008080398A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008080398A1 (en) * 2007-01-05 2008-07-10 Bkg Pharma Aps Anti - infective agents such as phenothiazine and thioxanthene derivates to treat infectious diseases
EP2246349A1 (en) 2009-04-20 2010-11-03 BKG Pharma ApS Treatment of infectious diseases
CN103172591B (zh) * 2013-03-13 2014-07-30 陕西科技大学 含吩噻嗪基的Schiff碱类化合物及其制备方法和应用
CN103709122B (zh) * 2013-11-29 2016-05-25 四川大学 用于治疗的抗肿瘤和抗真菌化合物
KR20190025920A (ko) * 2016-06-23 2019-03-12 바이오이믹스 아베 항-감염 헤테로사이클릭 화합물 및 이의 용도
CN112353805A (zh) * 2020-11-17 2021-02-12 北京化工大学 氟哌噻吨在治疗和预防柯萨奇病毒感染中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE578983A (ru) 1958-05-29
DE1210890B (de) 1960-03-07 1966-02-17 Smith & Kline & French Lab Verfahren zur Herstellung von Trifluormethyl-xanthen- oder thioxanthenderivaten
GB1453828A (en) * 1972-12-08 1976-10-27 Kefalas As Fluoro-substituted thiaxanthene derivatives
US4407800A (en) * 1981-11-02 1983-10-04 University Of Virginia Alumni Patents Foundation Protozoacidal activity of phenothiazines
AU625071B2 (en) * 1988-04-20 1992-07-02 Merrell Dow Pharmaceuticals Inc. N-alkylamino derivatives of aromatic, tricyclic compounds in the treatment of drug-resistant protozoal infections
US20020151543A1 (en) * 1998-05-28 2002-10-17 Sepracor Inc. Compositions and methods employing R (-) fluoxetine and other active ingredients
FR2813792B1 (fr) * 2000-09-12 2003-03-14 Inst Necker Moyens pour la regulation des defenses immunitaires
US6569853B1 (en) * 2000-11-06 2003-05-27 Combinatorx, Incorporated Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
RU2330642C2 (ru) 2001-07-06 2008-08-10 Лайфсайкл Фарма А/С Регулируемая агломерация
AU2003222197A1 (en) * 2002-01-16 2003-09-02 The Regents Of The University Of California Inhibition of rna function
US20060193788A1 (en) * 2002-11-26 2006-08-31 Hale Ron L Acute treatment of headache with phenothiazine antipsychotics
AU2003205543A1 (en) 2003-01-14 2004-08-10 Lifecycle Pharma A/S Dry dispersions
MXPA06001599A (es) * 2003-08-13 2006-05-19 Kudos Pharm Ltd Aminopironas y su uso como inhibidores de atm.
CA2564684C (en) * 2004-04-30 2010-10-26 Bkg Pharma Aps Use of thioxanthene derivatives as chemosensitising compounds
WO2006094207A2 (en) * 2005-03-03 2006-09-08 St. Jude Children's Research Hospital Substituted phenoxazines and acridones as inhibitors of akt
WO2008080398A1 (en) * 2007-01-05 2008-07-10 Bkg Pharma Aps Anti - infective agents such as phenothiazine and thioxanthene derivates to treat infectious diseases
EP2246349A1 (en) * 2009-04-20 2010-11-03 BKG Pharma ApS Treatment of infectious diseases

Also Published As

Publication number Publication date
NZ577821A (en) 2012-07-27
WO2008080398A1 (en) 2008-07-10
ES2367151T3 (es) 2011-10-28
CA2673809C (en) 2013-08-13
AU2008203743B2 (en) 2012-07-12
CN101594869A (zh) 2009-12-02
DK2114406T3 (da) 2011-09-12
AU2008203743A1 (en) 2008-07-10
EA016886B1 (ru) 2012-08-30
PL2114406T3 (pl) 2011-10-31
HRP20110607T1 (hr) 2011-09-30
CN101594869B (zh) 2013-08-07
CA2673809A1 (en) 2008-07-10
MX2009007235A (es) 2009-10-16
CY1111778T1 (el) 2015-10-07
WO2008080408A1 (en) 2008-07-10
JP2013173752A (ja) 2013-09-05
JP2010514814A (ja) 2010-05-06
EP2114406A1 (en) 2009-11-11
ATE510540T1 (de) 2011-06-15
PT2114406E (pt) 2011-08-25
HK1139309A1 (en) 2010-09-17
EP2114406B1 (en) 2011-05-25
US20100113430A1 (en) 2010-05-06
EP2301545A1 (en) 2011-03-30
JP5399921B2 (ja) 2014-01-29

Similar Documents

Publication Publication Date Title
MXPA06012566A (es) Tratamiento de enfermedades infecciosas.
ECSP10010582A (es) Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
GT200900095A (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas.
PE20121617A1 (es) Derivados de oxazina como inhibidores de bace
SV2009003299A (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa
MA33806B1 (fr) Inhibiteurs du virus de l'hepatite c
UA108743C2 (uk) Похідні хіназолін-4(3н)-ону для застосування як інгібіторів рі3-кінази
CO6480927A2 (es) Derivados de imidazolin-2-ona 1,3-disustituida como inhibidores de cyp17.
SV2011003855A (es) Heteroarilos sustituidos
UA109667C2 (xx) Похідні хіназолін-4(3h)-ону, що використовуються як інгібітори pi3-кінази
GT200800242A (es) Derivados biciclicos como inhibidores de cetp
CY1111778T1 (el) Παραγωγα θειοξανθενιου ως μοναδικοι αντιμολυσματικοι παραγοντες για χρηση στην αντιμετωπιση των μολυσματικων ασθενειων
EA200801996A1 (ru) 2-замещенные производные 4-бензилфталазинонов в качестве гистаминовых h1- и h3-антагонистов
CY1112758T1 (el) Καινοτομοι ανταγωνιστες p2x7r και η χρηση τους
DK2236149T3 (da) Medicinsk sammensætning til behandling af respiratoriske infektions-sygdomme
ECSP12011959A (es) SALES DE 4-[2-[[5-METIL-1-(2-NAFTALENIL)-1H-PIRAZOL-3-il]OXI]ETIL]MORFOLINA
ATE517873T1 (de) 6-oxo-1,6-dihydropyrimidin-2-yle bei der behandlung proliferativer krankheiten
MA32841B1 (fr) Composés de cycloundeca depsipeptides et leur utilisation comme médicament
UA107346C2 (en) Use of nifuratel to treat infections caused by atopobium species
FR2943537B1 (fr) Traitement des nevrites vestibulaires par l'acetyl-l-leucine
EA201171269A1 (ru) Лечение инфекционных болезней
ATE474574T1 (de) Imidazoazephinonverbindungen
BRPI1008188A2 (pt) "derivados de 6-(6-nh-subistituído-triazolopiridazina-sulfanil) benzotiazóis e benzimidazóis: preparo, aplicação como medicamentos e utilização como inibidores de met"
EA200801678A1 (ru) Применение производных триазина для производства лекарственного средства, обладающего заживляющим или ангиогенным эффектом

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ BY KZ RU